Delivery Order SPE2DB24D2011-SPE2DB25FBPCG

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $58K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,341.10 fixed-price delivery order is for 60 tablets of the medication Sprycel (dasatinib) 50 mg. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sprycel 140 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,240.50 and a performance period through April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award is for the delivery of pharmaceutical products, primarily the drug Sprycel 100 mg tablet, to support the medical needs of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,503.06. It has an ultimate completion date of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,769.38 firm fixed price delivery order is for the supply of the prescription drug Sprycel 50 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Sprycel 100 mg tablets. The $16,006.11 firm-fixed-price delivery order contract has a completion date of June 21, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sprycel 70 mg tablets. The contract is a Delivery Order valued at $9,190.91 with a firm fixed price and an ultimate completion date of May 22, 2024. Amerisourcebergen, through its Corporate Office division, has extensive experience fulfilling government contracts for a wide range of prescription medications, over-the-counter drugs, and...
This federal contract award, valued at $34,736.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,568,143,511 tablets of the prescription medication Sprycel (100 mg) to the government. The contract has a firm fixed price and an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Sprycel 50 mg tablets. The $11,613.06 firm fixed-price delivery order contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, enabling them to efficiently supply a wide range of pharmaceutical and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBPCG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,685.10 firm-fixed-price delivery order contract is for the supply of the drug Sprycel (dasatinib) 50 mg tablets. The contract has an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This contract award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 1/30/25, 9:10 AM